Daniel S. Berman, MD
Cedars-Sinai Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Daniel S. Berman, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:10 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03689946 · Effect of Evolocumab on Coronary AtherosclerosisCedars-Sinai Medical Center · completed · Cardiovascular Disease, Hyperlipidemia · principal investigator
- Ph2NCT03095313 · 18-F Sodium Fluoride (18F-NaF) PET for the Assessment of Bioprosthetic Aortic Valve Durability and OutcomesCedars-Sinai Medical Center · completed · Aortic Stenosis · principal investigator
- N/ANCT01986868 · Identification of Adverse Plaque Characteristics by Coronary MR AngiographyCedars-Sinai Medical Center · completed · Coronary Artery Disease
- N/ANCT01949844 · Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion StudiesDaniel S. Berman · completed · Coronary Artery Disease, CAD
- N/ANCT00892307 · Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)Cedars-Sinai Medical Center · completed · Coronary Artery Disease
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.